Image
St. Louis-founded C2N Diagnostics, a leader in advanced brain health diagnostics, is tripling the size of its operations in its hometown. The company’s expansion includes the relocation of its headquarters to Catalyst, Powered by WashU — the former Goodwill Building in Cortex Innovation District — as it meets the global need for answers to Alzheimer’s Disease.
"C2N’s expansion in St. Louis is yet another example of our region’s strength in neuroscience research,” said Dustin Allison, Interim CEO, Greater St. Louis, Inc. "C2N’s investment here is not only deeply important to human health, but also to our region’s economic development. C2N's announcement is clear evidence that growth and innovation are valued in this region, and that our community will work in intentional, collaborative ways with business partners looking for a welcoming place to grow their enterprise."
Earlier this year, the St. Louis Board of Aldermen passed legislation supporting WashU’s $100 million redevelopment of the former Goodwill Building, support that helped C2N not only stay in St. Louis where it was founded, but expand as the building’s anchor tenant, serving as a hub for groundbreaking neuroscientific research.
“I am so pleased that C2N Diagnostics chose to remain in the city where it was founded, and that it will be housed in a building renovated and backed by WashU,” said Dr. David Holtzman, C2N Co-Founder. “The company’s future is bright, and the new headquarters at Catalyst will support growth, collaboration and advancement as its researchers seek new tools to better diagnose, prevent and treat Alzheimer’s disease and other neurodegenerative conditions.”
Greater St. Louis, Inc. is proud to have joined local and state partners in supporting C2N during its expansion process, including Missouri Governor Mike Kehoe; Mayor Cara Spencer, City of St. Louis; Alderman Michael Browning, City of St. Louis; Cortex Innovation District; Cushman & Wakefield; Missouri Department of Economic Development; St. Louis Development Corporation; and Washington University in St. Louis.
More:
- Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease (C2N Diagnostics)
- C2N Diagnostics to expand in St. Louis, investing millions of dollars and preparing for significant hiring (Missouri Department of Economic Development)
- WashU outlines plans for reimagined Goodwill complex (WashU)